本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Mersana Therapeutics Inc.

0.3977
-0.0023-0.57%
盘后0.3878-0.0099-2.49%19:29 EDT
成交量:156.52万
成交额:60.66万
市值:4,956.59万
市盈率:-0.70
高:0.4099
开:0.4067
低:0.3751
收:0.4000
数据加载中...
2021/05/10

重要事件披露

8-K - Current report
2021/04/09

重要事件披露

8-K - Current report
2021/03/11

重要事件披露

8-K - Current report
2021/02/26

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/26

重要事件披露

8-K - Current report
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/12

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/04

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/27

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/25

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/01/12

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/01/05

重要事件披露

8-K - Current report
2020/12/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/30

重要事件披露

8-K - Current report
2020/11/19

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/11/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/09

重要事件披露

8-K - Current report
2020/09/22

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2020/09/17

重要事件披露

8-K - Current report